Brain MRI findings in patients with Fabry disease

Ricardo C Reisin1, Carlos Romero, Cintia Marchesoni

  • 1Neurology Department, Hospital Británico de Buenos Aires, Argentina. rcreisin@intramed.net

Abstract

Insights

Brain MRI revealed small vessel disease in 44.4% of adult Fabry disease (FD) patients and microbleeds in 11%. FD should be considered in diagnosing ischemic and hemorrhagic brain lesions.

Area of Science:

  • Neurology
  • Radiology
  • Genetics

Background:

  • Fabry disease (FD) is a rare genetic disorder that can affect multiple organs, including the brain.
  • Cerebral involvement in FD can manifest as ischemic or hemorrhagic lesions, often detected via MRI.
  • Early diagnosis and management are crucial for preventing severe neurological complications.

Purpose of the Study:

  • To investigate the prevalence of ischemic and hemorrhagic lesions in the brains of patients with Fabry disease using MRI.
  • To identify specific MRI findings associated with Fabry disease, including small vessel disease and microbleeds.

Main Methods:

  • Brain MRI scans of 46 consecutive patients with Fabry disease were analyzed.
  • Classic MRI sequences and GRE-weighted images were used to detect ischemic lesions and chronic microbleeds.
  • Patient data, including age, sex, and clinical symptoms, were correlated with MRI findings.

Main Results:

  • Ten pediatric patients (under 20) had normal initial MRIs; one developed an occipital lesion.
  • 44.4% of adult patients (36 total) exhibited signs of small vessel disease in various brain regions.
  • Three adult women presented with deep chronic microbleeds detected by GRE sequences.

Conclusions:

  • A significant proportion of adult Fabry disease patients without a history of stroke show MRI evidence of small vessel disease and cerebral microbleeds.
  • Fabry disease should be routinely considered in the differential diagnosis for young adults presenting with ischemic or microhemorrhagic brain lesions.
  • MRI is a valuable tool for detecting and characterizing cerebrovascular complications in Fabry disease.